# Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy

> **NCT06048289** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Biliary Tract Tumor
- Cholangiocarcinoma

## Interventions

- **OTHER:** Blood samples, tumor biopsy specimens will be collected

## Key facts

- **NCT ID:** NCT06048289
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-14
- **Primary completion:** 2024-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048289, "Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06048289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*